AI assistant
BIO-TECHNE Corp — Director's Dealing 2021
Mar 3, 2021
30718_dirs_2021-03-03_1104608c-ff81-40b8-9ae3-ab3d7c7a7fb6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2021-03-01
Reporting Person: Furlow Brenda S. (SVP - General Counsel)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-01 | Stock Options (Right to Buy) | $372.44 | A | 10997 | Acquired | 2028-03-01 | Common Stock (10997) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6124 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $108.49 | 2022-08-07 | Common Stock (921) | 921 | Direct |
| Stock Options (Right to Buy) | $106.59 | 2023-08-18 | Common Stock (3538) | 3538 | Direct |
| Stock Options (Right to Buy) | $125.05 | 2024-08-09 | Common Stock (9503) | 9503 | Direct |
| Stock Options (Right to Buy) | $125.05 | 2024-08-09 | Common Stock (12670) | 12670 | Direct |
| Restricted Stock Units | $ | Common Stock (1374) | 1374 | Direct | |
| Stock Options (Right to Buy) | $177.32 | 2025-08-08 | Common Stock (7339) | 7339 | Direct |
| Stock Options (Right to Buy) | $177.32 | 2025-08-08 | Common Stock (9786) | 9786 | Direct |
| Restricted Stock Units | $ | Common Stock (1969) | 1969 | Direct | |
| Stock Options (Right to Buy) | $190.41 | 2026-08-07 | Common Stock (9968) | 9968 | Direct |
| Stock Options (Right to Buy) | $190.41 | 2026-08-07 | Common Stock (13290) | 13290 | Direct |
| Restricted Stock Units | $ | Common Stock (1679) | 1679 | Direct | |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (7492) | 7492 | Direct |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (9990) | 9990 | Direct |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (8325) | 8325 | Direct |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (8325.0) | 8325.0 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2: Fully exercisable.
F3: Options to purchase 3,167 shares vest on each of 8/9/2018 and 8/9/2019 and options to purchase 3,168 shares vest on each of 8/9/2020 and 8/9/2021.
F4: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F5: Options to purchase 2,447 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 2,446 shares vest on each of 8/8/2021 and 8/8/2022.
F6: Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7: Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023.
F8: Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F9: Options to purchase 2,498 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,497 shares vest on each of 8/5/2023 and 8/5/2024.
F10: Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021
F11: Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.